Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01438177. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01592370. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01816971. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple Myeloma
ClinicalTrials.gov study NCT01050790. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy
ClinicalTrials.gov study NCT04436029. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients
ClinicalTrials.gov study NCT00103662. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens
ClinicalTrials.gov study NCT03412565. IPD Sharing: Not stated. Countries: 9. Publications: 1.
An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments
ClinicalTrials.gov study NCT03828292. IPD Sharing: NO. Countries: 1. Publications: 1.
ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT02757326. IPD Sharing: NO. Countries: 1. Publications: 2.
Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT03710603. IPD Sharing: NO. Countries: 13. Publications: 4.
Lenalidomide Maintenance Therapy for Multiple Myeloma
ClinicalTrials.gov study NCT01675141. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05932290. IPD Sharing: NO. Countries: 1. Publications: 1.
APRIL CAR T Cells (AUTO2) Targeting BCMA and TACI for the Treatment of Multiple Myeloma
ClinicalTrials.gov study NCT03287804. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT04162210. IPD Sharing: NO. Countries: 19. Publications: 1.
An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Mul
ClinicalTrials.gov study NCT00555906. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT02252172. IPD Sharing: Not stated. Countries: 13. Publications: 10.
Study Evaluating the Safety and Tolerability of Weekly Dosing of Oral IXAZOMIB in Adult Patients With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00963820. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma
ClinicalTrials.gov study NCT00635154. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
ClinicalTrials.gov study NCT01413178. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment
ClinicalTrials.gov study NCT05014412. IPD Sharing: YES. Countries: 4. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.